Correlation Between BioLineRx and Collplant Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioLineRx and Collplant Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLineRx and Collplant Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLineRx and Collplant Biotechnologies, you can compare the effects of market volatilities on BioLineRx and Collplant Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLineRx with a short position of Collplant Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLineRx and Collplant Biotechnologies.

Diversification Opportunities for BioLineRx and Collplant Biotechnologies

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between BioLineRx and Collplant is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding BioLineRx and Collplant Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collplant Biotechnologies and BioLineRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLineRx are associated (or correlated) with Collplant Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collplant Biotechnologies has no effect on the direction of BioLineRx i.e., BioLineRx and Collplant Biotechnologies go up and down completely randomly.

Pair Corralation between BioLineRx and Collplant Biotechnologies

Given the investment horizon of 90 days BioLineRx is expected to generate 1.36 times more return on investment than Collplant Biotechnologies. However, BioLineRx is 1.36 times more volatile than Collplant Biotechnologies. It trades about 0.0 of its potential returns per unit of risk. Collplant Biotechnologies is currently generating about -0.02 per unit of risk. If you would invest  68.00  in BioLineRx on August 27, 2024 and sell it today you would lose (40.00) from holding BioLineRx or give up 58.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

BioLineRx  vs.  Collplant Biotechnologies

 Performance 
       Timeline  
BioLineRx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Collplant Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collplant Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

BioLineRx and Collplant Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioLineRx and Collplant Biotechnologies

The main advantage of trading using opposite BioLineRx and Collplant Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLineRx position performs unexpectedly, Collplant Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will offset losses from the drop in Collplant Biotechnologies' long position.
The idea behind BioLineRx and Collplant Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies